Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

β-Cell failure in type 2 diabetes.

Gil Leibowitz1, Nurit Kaiser1, Erol Cerasi1

  • 1Endocrine Services, Department of Medicine, Hebrew University Hadassah Medical Center, Jerusalem, Israel.

Journal of Diabetes Investigation
|May 21, 2014
PubMed
Summary

Type 2 diabetes is characterized by insulin resistance and diminished insulin response. Early loss of first-phase insulin secretion predicts future diabetes, suggesting functional rather than structural beta-cell issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same author

CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease.

npj metabolic health and disease·2026
Same author

Glucosamine links hyperglycemia to mTORC1 activation and glucose toxicity in diabetes.

JCI insight·2026
Same author

JNK3 regulates β cell responses to incretins in human islets and mouse models.

The Journal of clinical investigation·2026
Same author

Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study.

Cardiovascular diabetology·2025
Same author

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data.

Diabetes/metabolism research and reviews·2025

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Type 2 diabetes involves insulin resistance, often linked to obesity and sedentary lifestyles.
  • Diminished insulin response to nutrients is a hallmark of type 2 diabetes.
  • Impaired glucose regulation necessitates insulin deficiency, with early loss of first-phase insulin response to glucose.

Purpose of the Study:

  • To explore the underlying mechanisms of beta-cell dysfunction in type 2 diabetes.
  • To investigate the role of functional versus structural beta-cell deficits.
  • To examine the impact of genetic factors and cellular stress on beta-cell function and survival.

Main Methods:

  • Review of prospective studies on insulin response and diabetes prediction.
Keywords:
Insulin resistanceInsulin secretionβ‐Cell failure

Related Experiment Videos

  • Analysis of research on type 2 diabetes risk gene variants affecting beta-cell function.
  • Examination of studies on beta-cell mass in diabetic and normoglycemic individuals.
  • Investigation of in vitro models of beta-cell response to glucolipotoxicity, endoplasmic reticulum stress, and oxidative stress.

    • Main Results:

    • Impaired insulin response to glucose predicts future impaired glucose tolerance and type 2 diabetes.
    • Type 2 diabetes may develop from 'weak' beta-cells unable to meet demands of overnutrition and insulin resistance.
    • Beta-cell dysfunction appears primarily functional initially, though progressive hyperglycemia/hyperlipemia can induce apoptosis via glucolipotoxicity.
    • Endoplasmic reticulum and oxidative stress in beta-cells are linked to glucolipotoxic conditions.

    Conclusions:

    • Beta-cell dysfunction, particularly impaired insulin secretion, is central to type 2 diabetes development.
    • While initially functional, beta-cell mass may decrease progressively due to glucolipotoxicity.
    • Endoplasmic reticulum stress and oxidative stress, potentially involving TXNIP, are implicated in beta-cell apoptosis and type 2 diabetes.
    • Understanding these cellular mechanisms may pave the way for novel therapeutic strategies.